首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Jonas Frisen had’ his eureka moment in 1997. Back then, scientists suspected that there was a special type of cell in the brain
Jonas Frisen had’ his eureka moment in 1997. Back then, scientists suspected that there was a special type of cell in the brain
admin
2011-02-11
13
问题
Jonas Frisen had’ his eureka moment in 1997. Back then, scientists suspected that there was a special type of cell in the brain that had the power to give rise to new brain cells. If they could harness these so-called neural stem cells to regenerate damaged brain tissue, they might someday find a cure for such brain diseases as Alzheimer’s and Parkinson’s. But first they had to figure out where neural stem cells were and what they looked like. Frisen, then a freshly minted Ph. D. at the Karolinska Institute in Stockholm, was peering through his microscope at some tissue taken from a rat’s injured spinal cord when he saw cells that appeared to have been enervated by the injury, as though they were busy making repairs. Frisen thought these might be the neural stem cells scientists had been looking for. It took him six years of painstaking research to make sure.
Frisen is quick to emphasize that his research is basic and that treatments are years off. But the findings so far hint at extraordinary potential. Two years ago he identified neural stem cells in the adult human brain. And he’s now researching the mechanisms by which these cells grow into different types of brain cells. Rather than growing brain tissue in a petri-dish and implanting it in, say, the forebrain of a Parkinson’s patient, doctors might someday stimulate the spontaneous growth of new neural cells merely by administering a drug. "It sounds like science fiction," Frisen says, "but we can already do it in mice." In 2007 he will publish the results of his recent experiments. He’s isolated a protein in the mouse brain that inhibits the generation of nerve cells. Using other chemicals, he’s been able to block the action of this inhibitor, which in turn leads to the production of new brain cells.
Frisen honed his analytical mind at the dinner table in Goteborg, in southwest Sweden. His mother was a mathematics professor and his father was an ophthalmologist. Frisen went to medical school intending to be a brain surgeon or perhaps a psychiatrist, but ended up spending all his free time in the lab. In 1998 he got seed money from a Swedish venture capitalist to set up his own company, NeuroNova, to commercialize his work. A private foundation tried to lure him to Texas, but Swedish businessman Marcus Storch persuaded him to stay by funding a 15-year professorship at Karolinska, eovering his salary and the running costs of his 15-person lab. "Jonas Frisen stood out from all candidates by far," says Storch, whose Tobias Foundation sponsors stem-cell research. "He is something of a king in Sweden." Two years ago two more venture capitalists helped the company expand by hiring a CEO and setting up a separate lab.
Since most researchers are interested in stem cells taken from embryos, the practice has attracted considerable controversy in the past few years. Frisen has benefited indirectly from research restrictions in the United States, which have driven funds and brain-power to Singapore, the United Kingdom and Sweden. The Bush Administration currently forbids U. S. -funded work on all but 78 approved stem-cell cultures, many of which are located outside the country. In just one sign of the times, the U. S. -based Juvenile Diabetes Research Foundation recently announced grants totaling $ 20 million for stem-cell research—the largest award yet given to the field by a medical charity—to research institutes in Sweden and elsewhere, but not in the United States.
Since Frisen doesn’t work with embryonic stem cells, he’s unwittingly become a champion of the radical fight, which argues that scientists ought to concentrate solely on adult stem ceils. He happens to disagree. "It would be overoptimistic or outright stupid," he says. "To really understand adult cells, we need to master how embryonic stem cells work." But what really gets Frisen going is when people ask him when they can expect a drug for Parkinson’s and other diseases. "I say, five decades, just to get the number thing out of the way," he quips. "I’m not going to oversell this." When pressed, he admits that clinical trials might begin in five years. That would be a eureka moment worth waiting for.
As to the stem-cell research, the Bush Administration’s attitude is one of
选项
A、skepticism.
B、disapproval.
C、ambivalence.
D、prudence.
答案
B
解析
由题干中的the Bush Administration定位至第四段。第三句指出布什政府现在禁止干细胞培养项目,即使同意的一些项目也是在国外进行的。可见,布什政府对干细胞研究持否定态度,故B为答案。C意为“举棋不定”,与文意不符,排除。D意为“审慎的”,程度不够,排除。
转载请注明原文地址:https://jikaoti.com/ti/4gpYFFFM
0
专业英语八级
相关试题推荐
Ithasalwaysbeendifficultforthephilosopherorscientiststofittimeintohisviewoftheuniverse.PriortoEinsteinianp
ThenumberofscientistsandengineersgoingtoAmericatostudyandworkisdroppingprecipitously.Animportantreasonisthe
ThomasJefferson,whodiedin1826,loomseverlargerasafigureofspecialsignificance.Americans,ofcourse,arefamiliarwi
Whenscientistsfirstwarnedinthe1970sthatCFCscouldattackozone,theU.S.respondedbybanningtheiruseinspraycans.B
There’sasimpleideathattwoofWestGermany’stopcarmanufacturersseriouslystudyingatthemoment,bothoutofselfintere
ResearchintoDNAhashadasignificantimpactonmedicine.ThroughrecombinantDNAtechnology,scientistscanmodifymicroorgan
ResearchintoDNAhashadasignificantimpactonmedicine.ThroughrecombinantDNAtechnology,scientistscanmodifymicroorgan
随机试题
国标规定内螺纹大径应画()。
A.柠檬酸循环B.甲硫氨酸循环C.嘌呤核苷酸循环D.乳酸循环参与生成SAM的生化过程是
选用口外弓推磨牙远移时,内弓前部与切牙唇面的位置关系是
A.地尔硫革(硫氮革酮)B.洋地黄C.阿托品D.利多卡因E.胺碘酮急性前壁心肌梗死并发加速性室性自主律时宜选择的治疗药物为
海关对享受特定减免税进口的家用电器的监管年限为()年。
甲卷烟厂购进一批烟叶,委托某县城乙卷烟厂加工一批烟丝,该批烟叶不含增值税成本18万元,乙卷烟厂收取加工费3万元(不含增值税),乙卷烟厂无同类烟丝的销售价格。甲卷烟厂提货时乙卷烟厂代收代缴了消费税,该批烟丝收回后,甲卷烟厂将其中的60%以22万元价格(不含增
下列属于银行市场定位中的产品定位手段的是()。
资本公积转增资本和盈余公积转增资本,企业所有者权益总额不会发生变化。()
宋代著名的两大类书是()和()。
下列关于栈的叙述中,正确的是
最新回复
(
0
)